Abstract
Macroautophagy (hereafter simply called “autophagy”) is commonly induced by cancer treatments and has been widely reported to affect the treatment response. However, autophagy may be a double-edged sword with conflicting and competing tumor cell-intrinsic and -extrinsic effects that can inhibit and promote tumor initiation, promotion, progression, and metastasis. These complexities make it critical to understand how autophagy affects tumor cell response to treatment in order to better determine how or even whether we should try to manipulate during cancer therapy and thus improve clinical outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altman BJ, Jacobs SR, Mason EF et al (2011) Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis. Oncogene 30:1855–1867
Amaravadi RK, Thompson CB (2007) The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 13:7271–7279
Amaravadi RK, Lippincott-Schwartz J, Yin X-M et al (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17:654–666
Apel A, Herr I, Schwarz H et al (2008) Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 68:1485–1494
Apetoh L, Ghiringhelli F, Tesniere A et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050–1059
Bassi R, Giussani P, Anelli V et al (2008) HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J Neurooncol 87:23–33
Bursch W, Ellinger A, Kienzl H et al (1996) Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 17:1595–1607
Dupont N, Jiang S, Pilli M et al (2011) Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J 30:4701–4711
Duran A, Linares JF, Galvez AS et al (2008) The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 13:343–354
Elgendy M, Sheridan C, Brumatti G et al (2011) Oncogenic Ras-induced expression of noxa and beclin-1 promotes autophagic cell death and limits clonogenic survival. Mol Cell 42:23–35
Facciabene A, Santoro S, Coukos G (2012) Know thy enemy: why are tumor-infiltrating regulatory T cells so deleterious? Oncoimmunology 1:575–577
Gonzalez-Malerva L, Park J, Zou L et al (2011) High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci USA 108:2058–2063
Guo JY, Chen H-Y, Mathew R et al (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25:460–470
He C, Levine B (2010) The Beclin 1 interactome. Curr Opin Cell Biol 22:140–149
Kimmelman AC (2011) The dynamic nature of autophagy in cancer. Genes Dev 25:1999–2010
Komatsu M, Kurokawa H, Waguri S et al (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12:213–223
Kon M, Kiffin R, Koga H et al (2011) Chaperone-mediated autophagy is required for tumor growth. Sci Transl Med 3(109):109ra117
Kondo Y, Kondo S (2006) Autophagy and cancer therapy. Autophagy 2:85–90
Kroemer G, Marino G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40:280–293
Lazova R, Camp RL, Klump V et al (2012) Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome. Clin Cancer Res 18:370–379
Lee IH, Kawai Y, Fergusson MM et al (2012) Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress. Science 336:225–228
Levine B, Mizushima N, Virgin HW (2011) Autophagy in immunity and inflammation. Nature 469:323–335
Levy JM, Thorburn A (2011) Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther 131:130–141
Li Y, Hahn T, Garrison K et al (2012) The vitamin E analogue α-TEA stimulates tumor autophagy and enhances antigen cross-presentation. Cancer Res 72:3535–3545
Liang C, Feng P, Ku B et al (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8:688–698
Lock R, Roy S, Kenific CM et al (2011) Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell 22:165–178
Maiuri MC, Tasdemir E, Criollo A et al (2009) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 16:87–93
Marino G, Salvador-Montoliu N, Fueyo A et al (2007) Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 282:18573–18583
Mathew R, Kongara S, Beaudoin B et al (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21:1367–1381
Mathew R, Karp CM, Beaudoin B et al (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137:1062–1075
Maycotte P, Thorburn A (2011) Autophagy and cancer therapy. Cancer Biol Ther 11:127–137
Maycotte P, Aryal S, Cummings CT et al (2012) Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8:200–212
McAfee Q, Zhang Z, Samanta A et al (2012) Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci USA 109:8253–8258
Michaud M, Martins I, Sukkurwala AQ et al (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334:1573–1577
Onda H, Lueck A, Marks PW et al (1999) Tsc2(+/−) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 104:687–695
Parkhitko A, Myachina F, Morrison TA et al (2011) Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci USA 108:12455–12460
Qadir MA, Kwok B, Dragowska WH et al (2008) Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization. Breast Cancer Res Treat 112:389–403
Qu X, Yu J, Bhagat G et al (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112:1809–1820
Radoshevich L, Murrow L, Chen N et al (2010) ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death. Cell 142:590–600
Randow F, Munz C (2012) Autophagy in the regulation of pathogen replication and adaptive immunity. Trends Immunol 33(10):475–487
Rubinstein AD, Eisenstein M, Ber Y et al (2011) The autophagy protein Atg12 associates with antiapoptotic Bcl-2 family members to promote mitochondrial apoptosis. Mol Cell 44:698–709
Saitoh T, Akira S (2010) Regulation of innate immune responses by autophagy-related proteins. J Cell Biol 189:925–935
Samaddar JS, Gaddy VT, Duplantier J et al (2008) A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Mol Cancer Ther 7:2977–2987
Shaid S, Brandts CH, Serve H et al (2012) Ubiquitination and selective autophagy. Cell Death Differ 20(1):21–30
Shen S, Kepp O, Michaud M et al (2011) Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 30:4544–4556
Sica A, Allavena P, Mantovani A (2008) Cancer related inflammation: the macrophage connection. Cancer Lett 267:204–215
Solomon VR, Lee H (2009) Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625:220–233
Takahashi Y, Coppola D, Matsushita N et al (2007) Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 9:1142–1151
Takamura A, Komatsu M, Hara T et al (2011) Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25:795–800
Thorburn A (2008) Studying autophagy’s relationship to cell death. Autophagy 4:391–394
Thorburn A, Debnath J (2011) Targeting chaperone-mediated autophagy in cancer. Sci Transl Med 3(109):109ps45
Thorburn J, Horita H, Redzic J et al (2009) Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 16:175–183
Virgin HW, Levine B (2009) Autophagy genes in immunity. Nat Immunol 10:461–470
White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12:401–410
Wilkinson S, O’Prey J, Fricker M et al (2009) Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity. Genes Dev 23:1283–1288
Yang ZJ, Chee CE, Huang S et al (2011a) Autophagy modulation for cancer therapy. Cancer Biol Ther 11:169–176
Yang S, Wang X, Contino G et al (2011b) Pancreatic cancers require autophagy for tumor growth. Genes Dev 25:717–729
Yousefi S, Perozzo R, Schmid I et al (2006) Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8:1124–1132
Yue Z, Jin S, Yang C et al (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100:15077–15082
Zhao Z, Oh S, Li D et al (2012) A dual role for UVRAG in maintaining chromosomal stability independent of autophagy. Dev Cell 22(5):1001–1016
Zitvogel L, Apetoh L, Ghiringhelli F et al (2008) The anticancer immune response: indispensable for therapeutic success? J Clin Invest 118:1991–2001
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thorburn, A., Morgan, M.J. (2013). Autophagy and Cancer Therapy. In: Wang, HG. (eds) Autophagy and Cancer. Current Cancer Research, vol 8. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6561-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6561-4_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6560-7
Online ISBN: 978-1-4614-6561-4
eBook Packages: MedicineMedicine (R0)